Enhancement of vasoreactivity andcognition by intranasal insulin in Type 2 diabetes

Diabetes Care

Volumn 37, Issue 3, 2014, Pages 751-759

  Novak, Vera ^a   Milberg, William ^a   Hao, Ying ^a,b   Munshi, Medha ^a,c   Novak, Peter ^d   Galica, Andrew ^a   Manor, Bradley ^a   Roberson, Paula ^e   Craft, Suzanne ^f   Abduljalil, Amir ^g  

^a HARVARD MEDICAL SCHOOL   (United States)

^b PEKING UNIVERSITY   (China)

^c JOSLIN DIABETES CENTER   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT HUMAN INSULIN; ANTIDIABETIC AGENT; INSULIN;

ADULT; ALLERGIC REACTION; ARTICLE; ATTENTION; BRAIN FUNCTION; BRAIN PERFUSION; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERCAPNIA; HYPOGLYCEMIA; INSULA; MALE; MIDDLE CEREBRAL ARTERY; NEUROPHYSIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOSE IRRITATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; SPATIAL MEMORY; SPEECH ARTICULATION; TASK PERFORMANCE; VASODILATATION; VISUAL MEMORY; BRAIN; BRAIN CIRCULATION; COGNITION; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; INTRANASAL DRUG ADMINISTRATION; MAGNETIC RESONANCE ANGIOGRAPHY; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; VASCULARIZATION;

ADMINISTRATION, INTRANASAL; BRAIN; CEREBROVASCULAR CIRCULATION; COGNITION; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; VASODILATION;

EID: 84896692580     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1672     Document Type: Article

References (36)

1. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 2004; 63:1181-1186
2. de Bresser J, Tiehuis AM, van den Berg E, et al.; Utrecht Diabetic Encephalopathy Study Group. Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care 2010;33:1309-1314
3. van den Berg E, Reijmer YD, de Bresser J, Kessels RP, Kappelle LJ, Biessels GJ; Utrecht Diabetic Encephalopathy Study Group. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia 2010;53:58-65
4. Moran C, Phan TG, Chen J, et al. Brain atrophy in type 2 diabetes: Regional distribution and influence on cognition. Diabetes Care. 12 August 2013 [Epub ahead of print]
5. Last D, Alsop DC, Abduljalil AM, et al. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 2007;30: 1193-1199
6. Novak V, Zhao P, Manor B, et al. Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes. Diabetes Care 2011;34:2438-2441
7. Tiehuis AM, Vincken KL, van den Berg E, et al. Cerebral perfusion in relation to cognitive function and type 2 diabetes. Diabetologia 2008;51:1321-1326
8. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-1625
9. Gunning-Dixon FM, Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 2000;14:224-232
10. Benedict C, Dodt C, Hallschmid M, et al. Immediate but not long-term intranasal administration of insulin raises blood pressure in human beings. Metabolism 2005;54:1356-1361
11. Benedict C, Kern W, Schultes B, Born J, Hallschmid M. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J Clin Endocrinol Metab 2008;93: 1339-1344
12. Craft S, Baker LD, Montine TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 2012;69:29-38
13. Hallschmid M, Benedict C, Schultes B, et al. Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders. Regul Pept 2008; 149:79-83
14. Thorne RG, Pronk GJ, Padmanabhan V, Frey WH 2nd. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 2004;127: 481-496
15. Hanson LR, Frey WH 2nd. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci 2008; 9(Suppl. 3):S5
16. Kerr D, Stanley JC, Barron M, Thomas R, Leatherdale BA, Pickard J. Symmetry of cerebral blood flow and cognitive responses to hypoglycaemia in humans. Diabetologia 1993;36:73-78
17. Reger MA, Watson GS, Green PS, et al. Intranasal insulin administration dosedependently modulates verbal memory and plasma amyloid-beta in memoryimpaired older adults. J Alzheimers Dis 2008;13:323-331
18. Wang Z, Aguirre GK, Rao H, et al. Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magn Reson Imaging 2008;26:261-269
19. D'Agostino E, Maes F, Vandermeulen D, Suetens P. Atlas-to-image non-rigid registration by minimization of conditional local entropy. Inf Process Med Imaging 2007;20:320-332
20. MacIntosh BJ, Pattinson KT, Gallichan D, et al. Measuring the effects of remifentanil on cerebral blood flow and arterial arrival time using 3D GRASE MRI with pulsed arterial spin labelling. J Cereb Blood Flow Metab 2008;28:1514-1522
21. Zhao P, Alsop DC, Abduljalil A, et al. Vasoreactivity and peri-infarct hyperintensities in stroke. Neurology 2009; 72:643-649
22. Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL. Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 2002;5:514-516
23. Benedict RHB, Schretlen D, Groninger L, Dobraski M, Sphritz B. Revision of the Brief VisuospatilaaMemory test: Studies of normal performance, reliability and validity. Psychol Assess 1996;8:145-153
24. Yeudall LT, Fromm D, Reddon JR, Stefanyk WO. Normative data stratified by age and sex for 12 neuropsychological tests. J Clin Psychol 1986;42:918-946
25. Eckert MA, Menon V, Walczak A, et al. At the heart of the ventral attention system: the right anterior insula. Hum Brain Mapp 2009;30:2530-2541
26. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006;113:1888-1904
27. Cranston I, Marsden P, Matyka K, et al. Regional differences in cerebral blood flow and glucose utilization in diabetic man: the effect of insulin. J Cereb Blood Flow Metab 1998;18:130-140
28. Reger MA, Watson GS, Frey WH 2nd, et al. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging 2006; 27:451-458
29. Muniyappa R, MontagnaniM, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev 2007;28:463-491
30. Novak V, Hajjar I. The relationship between blood pressure and cognitive function. Nat Rev Cardiol 2010;7:686-698
31. Dufor O, Serniclaes W, Sprenger-Charolles L, D́emonet JF. Top-down processes during auditory phoneme categorization in dyslexia: a PET study. Neuroimage 2007;34: 1692-1707
32. Abboud H, Berroir S, Labreuche J, Orjuela K, Amarenco P; GENIC Investigators. Insular involvement in brain infarction increases risk for cardiac arrhythmia and death. Ann Neurol 2006;59:691-699
33. Sachdev PS, Lipnicki DM, Crawford J, et al.; Sydney Memory, Ageing Study Team. Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study. PLoS ONE 2013;8:e59649
34. Benedict C, Hallschmid M, Schultes B, Born J, Kern W. Intranasal insulin to improve memory function in humans. Neuroendocrinology 2007;86:136-142
35. Reger MA, Craft S. Intranasal insulin administration: a method for dissociating central and peripheral effects of insulin. Drugs Today (Barc) 2006;42:729-739
36. Shemesh E, Rudich A, Harman-Boehm I, Cukierman-Yaffe T. Effect of intranasal insulin on cognitive function: a systematic review. J Clin Endocrinol Metab 2012;97: 366-376 Kidney Diseases